A Common Blood Pressure Drug Works Partly Through the Brain's Beta-Endorphin System

Alpha-methyldopa lowers blood pressure partly by activating beta-endorphin signaling in a key brainstem blood pressure control center, not through enkephalins or dynorphin.

Van Giersbergen, P L et al.·Brain research·1989·Preliminary EvidenceAnimal StudyAnimal Study
RPEP-00140Animal StudyPreliminary Evidence1989RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Alpha-methyldopa's hypotensive effect requires opioid receptor activation in the NTS, specifically through beta-endorphin and not through enkephalins or dynorphin.

Key Numbers

How They Did This

Conscious rats received microinjections of naltrexone or specific opioid peptide antisera into the NTS, followed by systemic alpha-methyldopa. Blood pressure was monitored.

Why This Research Matters

This revealed that a widely used blood pressure drug works partly through the brain's opioid system, connecting blood pressure regulation to natural opioid peptides.

The Bigger Picture

This finding revealed a surprising connection between a standard cardiovascular drug and the brain's natural opioid system. It suggests that endogenous opioid peptides play a broader role in blood pressure regulation than previously understood.

What This Study Doesn't Tell Us

Animal study using direct brain injection, which does not reflect how patients take the drug. Small study with limited statistical detail in the abstract.

Questions This Raises

  • ?Could enhancing beta-endorphin release in the NTS be a novel approach to blood pressure control?
  • ?Do other blood pressure medications also involve opioid pathways?

Trust & Context

Key Stat:
Beta-endorphin specific Only beta-endorphin blockade — not enkephalin or dynorphin — prevented alpha-methyldopa's blood pressure lowering effect in the brainstem
Evidence Grade:
Preliminary animal study using microinjections into specific brain regions. Mechanistically informative but not directly translatable to clinical practice.
Study Age:
Published in 1989. Alpha-methyldopa remains in clinical use, particularly for pregnancy-related hypertension, though its full mechanism of action is still being refined.
Original Title:
Participation of opiate receptors located in the nucleus tractus solitarii in the hypotension induced by alpha-methyldopa.
Published In:
Brain research, 498(1), 154-8 (1989)
Database ID:
RPEP-00140

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What is the nucleus tractus solitarii (NTS)?

The NTS is a brainstem region that acts as the brain's blood pressure control center. It receives signals from blood pressure sensors in blood vessels and adjusts heart rate and vessel tone accordingly.

How does beta-endorphin affect blood pressure?

Beta-endorphin activates opioid receptors in the NTS, which enhances the brain's blood-pressure-lowering signals. This study showed that alpha-methyldopa triggers this beta-endorphin pathway to achieve its therapeutic effect.

Read More on RethinkPeptides

Cite This Study

RPEP-00140·https://rethinkpeptides.com/research/RPEP-00140

APA

Van Giersbergen, P L; Roording, P; de Lang, H; de Jong, W. (1989). Participation of opiate receptors located in the nucleus tractus solitarii in the hypotension induced by alpha-methyldopa.. Brain research, 498(1), 154-8.

MLA

Van Giersbergen, P L, et al. "Participation of opiate receptors located in the nucleus tractus solitarii in the hypotension induced by alpha-methyldopa.." Brain research, 1989.

RethinkPeptides

RethinkPeptides Research Database. "Participation of opiate receptors located in the nucleus tra..." RPEP-00140. Retrieved from https://rethinkpeptides.com/research/van-1989-participation-of-opiate-receptors

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.